CYP 2C19 Polymorphism and Response to Adjunctive Cilostazol and High Maintenance-dose Clopidogrel in Patients Undergoing Elective Percutaneous Coronary Intervention.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cilostazol; Clopidogrel
- Indications Stent thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
Most Recent Events
- 17 May 2011 Biomarkers information updated
- 16 Mar 2010 Results were presented at the 59th Annual Scientific Session of the American College of Cardiology.
- 18 Nov 2009 New trial record